F
Fitzroy W. Dawkins
Researcher at Howard University
Publications - 47
Citations - 2209
Fitzroy W. Dawkins is an academic researcher from Howard University. The author has contributed to research in topics: Transferrin saturation & Hemochromatosis. The author has an hindex of 22, co-authored 47 publications receiving 2070 citations. Previous affiliations of Fitzroy W. Dawkins include Erasmus University Rotterdam & University of Washington.
Papers
More filters
Journal ArticleDOI
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
Paul C. Adams,David M. Reboussin,James C. Barton,Christine E. McLaren,John H. Eckfeldt,Gordon D. McLaren,Gordon D. McLaren,Fitzroy W. Dawkins,Ronald T. Acton,Emily L. Harris,Victor R. Gordeuk,Catherine Leiendecker-Foster,Mark Speechley,Beverly M. Snively,Joan Holup,Elizabeth J. Thomson,Phyliss Sholinsky +16 more
TL;DR: The C282y mutation is most common in whites, and most C282Y homozygotes have elevations in serum ferritin levels and transferrin saturation values in nonwhites.
Journal ArticleDOI
Enrollment of African Americans onto clinical treatment trials: study design barriers.
Lucile L. Adams-Campbell,Chiledum Ahaghotu,Melvin Gaskins,Fitzroy W. Dawkins,Duane T. Smoot,Octavius Polk,Robert Gooding,Robert L. DeWitty +7 more
TL;DR: It was evident that study design exclusion and inclusion criteria rendered the majority of the study population ineligible, and comorbidity is a major issue that warrants considerable attention among African Americans.
Journal ArticleDOI
Factors affecting cytochrome P-450 3A activity in cancer patients.
Sharyn D. Baker,Ron H.N. van Schaik,Laurent P. Rivory,Albert J. ten Tije,Kimberly Dinh,Wilfried J. Graveland,Paul W. Schenk,Kellie A. Charles,Stephen Clarke,Michael A. Carducci,William P. McGuire,Fitzroy W. Dawkins,Hans Gelderblom,Jaap Verweij,Alex Sparreboom +14 more
TL;DR: In this article, the authors identify the demographic, physiologic, and inheritable factors that influence CYP3A activity in cancer patients using the erythromycin breath test as a phenotyping probe.
Journal ArticleDOI
Hemochromatosis and iron overload screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults
Christine E. McLaren,James C. Barton,Paul C. Adams,Emily L. Harris,Ronald T. Acton,Nancy Press,David M. Reboussin,Gordon D. McLaren,Gordon D. McLaren,Phyliss Sholinsky,Ann P. Walker,Victor R. Gordeuk,Catherine Leiendecker-Foster,Fitzroy W. Dawkins,John H. Eckfeldt,Beverly G. Mellen,Mark Speechley,Elizabeth J. Thomson +17 more
TL;DR: Information from the HEIRS Study will inform policy regarding the feasibility, optimal approach, and potential individual and public health benefits and risks of primary care-based screening for iron overload and hemochromatosis.
Journal ArticleDOI
Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly
Albert J. ten Tije,Jaap Verweij,Michael A. Carducci,Wilfried J. Graveland,Theresa Rogers,Tatjana Pronk,M.P. Verbruggen,Fitzroy W. Dawkins,Sharyn D. Baker +8 more
TL;DR: Docetaxel plasma pharmacokinetics are unaltered in elderly patients, and patients aged >/= 65 years appear to be more sensitive to docetaxe-induced neutropenia.